Lapatinib 00480-3237-51

Package NDC

00480-3237-51

Manufacturer: Teva Pharmaceuticals, Inc.
Dosage Form: Tablet, Film Coated
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: December 19, 2024
Listing Expires: December 31, 2026
Application: ANDA217968

Need to source Lapatinib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Lapatinib Ditosylate	250 mg/1

Drug Class

Kinase Inhibitor [EPC]Protein Kinase Inhibitors [MoA]

Selected Package

00480-3237-51Selected

150 TABLET, FILM COATED in 1 BOTTLE (0480-3237-51)